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ABSTRACT 
Objectives: To verify the effectiveness of support power of underwear (the shaper) to 
elevate bladder neck and to reduce symptoms of stress urinary incontinence (SUI).  
Methods: This was a single-arm pilot study conducted in Japan by using the shaper 
(SLIM-up-Pants with Style Science
®
, Wacoal Corporation, Kyoto, Japan). The bladder 
neck position in a sitting posture was recorded using an open-configuration magnetic 
resonance system and then compared between parous women with SUI, without and with 
the shaper. Women wore the shaper during the daytime for 12 weeks, followed by one week 
during which they did not wear the shaper. The symptoms of urinary incontinence (UI) 
were assessed based on the 1-h pad test, the Japanese version of the International 
Consultation Incontinence Questionnaire-Short Form, and the incontinence diary. 
Results: Forty-five Japanese women with SUI, aged between 27 and 65 years, were 
included. When the shaper was worn, the bladder neck was found to be significantly 
elevated by 11.5 mm (median; P < 0.05/6 = 0.008). After 12 weeks, all symptoms of UI 
decreased significantly (P < 0.05/3 = 0.016), and the bladder neck was further elevated by 
4.7 mm (median; P < 0.001) even when not wearing the shaper. In addition, after one week 
of not wearing the shaper, the bladder neck position remained elevated and symptoms of UI 
did not recur immediately. 
Conclusion: The shaper was considered to be effective in elevating the bladder neck and 
reducing symptoms of UI. 
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Introduction 
Pelvic relaxation results in decreased support for the urinary tract and a descent of the 
bladder neck, leading to stress urinary incontinence (SUI). Urinary incontinence (UI) is 
reported to be experienced by 29% of healthy women in age group 30–60, and 78% of such 
cases are attributed to SUI
1
. Stress urinary incontinence is often considered embarrassing in 
women, and it has a negative impact on their quality of life (QOL)
 2
. Many women with 
SUI try to control themselves by using pads and going to a toilet regularly
3
.
 
Although SUI 
can be treated, most women with SUI do not consider treating it. On the other hand, some 
women have mild SUI and do not feel the necessity of treatment, because of its little 
influence on their daily life
4
. However, mild SUI may become aggravated later by risk 
factors such as pregnancy, delivery, aging, menopause, and obesity
5
. Therefore, early 
treatment and prevention are required. 
We are developing a new treatment for women with mild SUI, in which SUI is treated 
using an open-configuration magnetic resonance system GE SIGNA SP/2, 0.5 tesla (Open 
MR), which can be performed in a sitting or standing posture. In collaboration with the 
manufacturer, Wacoal Corporation (Kyoto, Japan), we are investigating the possibility of 
elevation in the bladder neck caused due to the use of the underwear, and also the validity 
of the product supportive underwear (SLIM-up-Pant with Style Science
®
; the shaper). The 
surgical treatment for SUI involves suspending the bladder neck or supporting the lower 
urinary tract by a sling
6
. This indicates that SUI may improve by elevating the bladder neck 
and supporting it with a support from the outside by underwear. If SUI could be reduced 
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simply by wearing underwear, which is easy to continue, it would be a good treatment for 
SUI. Therefore, in this study, we examined two research questions: 
(1) Is the bladder neck elevated due to the use of the shaper? 
(2) Does SUI reduce during the period of 12 weeks of use of the shaper? 
 
Methods 
Study design and setting 
This was a single-arm pilot study, interventional clinical trial based on a before-after 
design, aimed to verify the effectiveness of the shaper to elevate the bladder neck and 
reduce the symptoms of UI in parous women. This study was done from January 2009 to 
August 2010. 
Ethical considerations 
This study was approved by the ethical review board of Shiga University of Medical 
Science (20–69) and by the ethical review board of Kobe University Graduate School of 
Health Sciences (63), and it conforms to the provisions of the Declaration of Helsinki. All 
participants gave a signed informed consent. 
Participants 
The participants were parous women with SUI, as defined by the International 
Continence Society (ICS)
 7
. The inclusion criteria for the participants were as follows: age 
20–65 years, SUI or mixed urinary incontinence (MUI) with urinary leakage episodes at 
least once a week, and possibility of wearing the shaper for 12 weeks. The prevalence of 
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SUI in the women with a history of cesarean section is higher than in nulliparous women
8
, 
therefore, this study included women who had undergone cesarean section. The following 
were excluded: women within 3 months post-partum, women showing symptoms of only 
urge incontinence, pregnancy, use of medication affecting micturition, history of urological 
diseases expect UI or gynecological diseases or digestive diseases, and presence of metallic 
inserts such as pacemakers or artificial joints inside their bodies that cannot be removed 
during magnetic resonance imaging (MRI) scanning. The participants were recruited by 
advertising in local newspaper for women. 
The shaper 
The shaper used in this study was SLIM-up-Pant with Style Science
®
 (stock number; 
EQ0832, Wacoal Corporation, Kyoto, Japan). Style Science
®
 is a functional underwear 
with a cross structure (Japanese patent No. 3924586; United States patent No. 1752054), 
which stimulates the quadriceps femoris muscle, and promotes a large-stride during 
walking. The muscles of buttocks can be strengthened by walking more than 6000 steps per 
day, while wearing this underwear during the daytime for 12 weeks. In other words, this 
underwear was developed for muscle strengthening and for the correction of body shape, 
but not for elevating the bladder neck and reducing the symptoms of UI. It has the same 
shape as common long leg shapers, and most of the women are comfortable in shapers of 
suitable size. 
Measurements 
MRI for measuring the bladder neck position 
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The bladder neck position was assessed based on sagittal T1-weighted spoiled 
gradient-echo images of the pelvis, using a surface coil in a toilet seat and an Open MR 
taken in a sitting posture, because evaluation of the pelvic organ in SUI is better if done in 
a posture subject to vertical gravity
9
. 
Because MRI was performed without using any contrast agent, the participants were 
requested not to urinate for an hour before MRI to ensure full bladder. Image parameters 
used were repetition time of 68 ms, echo time of 4.3 ms (in phase), flip angle of 90°, field 
of view of 350 × 350 mm, matrix of 256 × 256, and slice thickness of 8 mm for three slices. 
MRI of the pelvis was performed in three motions: "at rest", "at pelvic floor muscle (PFM) 
contraction", and "at pelvic strain". The order was "at rest", "at PFM contraction", "at rest", 
"at pelvic strain". This was repeated twice, and the imaging time was 9 sec/motion. Before 
MRI, the participants were instructed by the researcher using the explanatory leaflet about 
"at PFM contraction" and "at pelvic strain". MRI was completed in 10 min. 
The bladder neck position was analyzed on the mid-sagittal images. The pubococcygeal 
line (PC line) was used to represent the normal location of the pelvic floor
10
. The PC line 
was used as the reference point (0 mm), the perpendicular distance up to the bladder neck 
was measured (in mm). Accordingly, the bladder neck position was shown as higher (+) or 
lower (−) with respect to the PC line. For each image, measurements  were performed twice, 
and the mean values were calculated. 
Symptoms of UI 
Four outcome measures were used evaluate the symptoms of UI: the 1-h pad test, the 
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Japanese version of the International Consultation Incontinence Questionnaire-Short Form 
(ICIQ-SF)
 11
, the number of incontinence episodes per week, and the frequency of voiding 
per day. The 1-h pad test was performed according to the recommendations by the ICS
12
, to 
evaluate severity and objective symptoms of UI. Higher ICIQ-SF scores indicate a greater 
severity of UI symptoms and a larger impact on the QOL. Since the Japanese version of the 
ICIQ-SF includes a question about the causes of urinary leakage, which was not included in 
the score, this question was used to differentiate between SUI and MUI in this study. The 
incontinence episodes and frequency of voiding were recorded daily by the participants in 
an incontinence diary. In this diary, free space was included for participants to enter 
changes, comments, etc. every day. 
Procedures 
Figure 1 shows the flow diagram of the study. First, for research question (1), the bladder 
neck position in a sitting posture was recorded using an Open MR, and it was compared 
between participants without and with the shaper. The interval between each MRI was 
about 5 min. Second, for research question (2), the participants wore the shaper during 
daytime and continued usual activities for 12 weeks, followed by one week during which 
they did not wear the shaper. This helped to verify whether UI symptoms recur 
immediately if the use of the shaper was stopped for one week, even if the UI were 
improved earlier. During the study period, the participants counted the number of steps 
using a pedometer. 
At the end of this study, the participants were asked whether they wanted to continue 
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wearing the shaper after this study, and were requested to grade how comfortable they were 
by wearing the shaper into five grades from "very good" to "very poor".  
Statistical analysis 
Statistical analyses were carried out using the software SPSS Version 19.0 for Windows 
(IBM Japan). Continuous data were checked for normality by Shapiro–Wilk tests. 
Subgroup analyses were performed using various tests as indicated in the Tables: Wilcoxon 
signed-ranks test, with or without Bonferroni correction ( = 0.05/3 = 0.016,  = 0.01/3 = 
0.003;  = 0.05/6 = 0.008), and 95% confidence intervals (CI) for the median difference 
using the Hodges-Lehmann estimator. P-values less than 0.05 were considered statistically 
significant. 
 
Results 
Study overview 
This was a single-arm pilot study conducted on Japanese women with SUI, implemented 
as depicted in Figure 1. Fifty women who wished to participate were telephonically 
screened, 45 of them participated and 41 completed this study (dropout rate: 8.9%). The 
characteristics of participants at baseline are shown in Table 1. Severity of UI was graded 
based on the standard of ICS in the 1-h pad test of baseline. Although there were 16 women 
(35.6%) who had undergone the pelvic floor muscle training before, none of them received 
the specialist’s instruction or were continuing it. Four women who dropped out had SUI, 
including two with slight and two with moderate UI. 
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Elevation of the bladder neck from wearing the shaper-research question (1) 
In "at rest" position, the bladder neck in women wearing the shaper was significantly 
higher than those without (P < 0.008). The extent of elevation was 11.5 mm (median; 95% 
CI, 10.0–12.9; Table 2). Moreover, wearing the shaper elevated the bladder neck in all 45 
women (100%). Likewise, the bladder neck position was significantly different between 
with and without the shaper for the other two motions, "at PFM contraction" and "at pelvic 
strain" (P < 0.008). Interestingly, the bladder neck position showed no difference 
(difference, 0.5 mm; 95% CI, −2.1 to 3.3; P > 0.008) between "at rest" without the shaper 
(median, 0.0 mm) and "at pelvic strain" with the shaper (median, 0.9 mm) (A vs. F). In 
other words, the results showed that the bladder neck position on wearing the shaper is 
maintained at the same height as “at rest” without the shaper, if the abdominal pressure is 
added. In addition, the bladder neck position "at rest" while wearing the shaper (median, 
11.7 mm) was significantly higher than the position "at PFM contraction" (median, 6.9 
mm) without the shaper (difference, 4.4 mm; 95% CI, 1.8–6.6; P < 0.008) (B vs. D). In 
other words, the results showed that the bladder neck position was elevated to a higher 
level than by performing voluntary PFM contraction by wearing the shaper. Figure 2 shows 
an example of MRI. 
Decrease in symptoms of UI by wearing the shaper-research question (2) 
Outcome measures were compared over the entire study period (Table 3). Compared to 
baseline, the 1-h pad test, the ICIQ-SF and the number of incontinence episodes per week 
were significantly decreased after 6 weeks of wearing the shaper (P < 0.003). In addition, 
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compared to baseline, at 12 weeks the 1-h pad test and the ICIQ-SF indicated a further 
decrease (P < 0.003) and the frequency of voiding per day was also decreased significantly 
(P < 0.016). Moreover, the bladder neck position without the shaper was more elevated 
than baseline after 12 weeks (difference, 4.7 mm; 95% CI, 2.8–6.6; P < 0.003). Next, 
compared to 12 weeks, there was no significant change in any of the four outcome 
measures related to UI, and no change in the bladder neck position after the one week 
follow-up, during which the participants did not wear the shaper (difference, 1.7 mm; 95% 
CI, −0.5 to 4.3; P > 0.016). In other words, these results showed that wearing the shaper in 
daytime for 12 weeks reduced symptoms of UI, and this effect was sustained for at least 
one week after stopping wearing the shaper. 
The symptoms of UI decreased or disappeared after 12 weeks in 35 of 41 women 
(85.4%). In addition, both MUI as well as SUI improved (Table 4). Moreover, this 
improvement did not relate to the severity of the UI symptoms; UI symptoms disappeared 
in two of three women with moderate UI, and in all three women with severe UI. The 
average steps as counted by pedometer for 12 weeks was 8713 steps/day (25th–75th 
percentile, 6650–10 247; n = 41). The number of steps did not correlate with the reduction 
of UI and elevation of the bladder neck position after 12 weeks. 
Safety and adherence of wearing the shaper 
No participant reported side-effects such as skin trouble or changes in voiding function 
on wearing the shaper for 12 weeks. These were confirmed from the notes of the 
participants in the free space of the incontinence diary, and by oral questioning. In addition, 
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when inquired at the end of the study, all participants wished to continue wearing the 
shaper even after the study. Further, all participants graded the comfort of wearing the 
shaper as "good" or "very good". 
 
Discussion 
This study verified the effectiveness of the shaper to elevate the bladder neck and to 
reduce the symptoms of UI in parous women. The major findings of this study revealed that 
wearing the shaper elevated the bladder neck in all participants; that even on adding an 
abdominal pressure, the bladder neck was maintained at the same position as that at rest 
without wearing the shaper; and that the bladder neck position was higher than that at 
voluntary PFM contractions without wearing the shaper. In addition, this study showed that 
wearing the shaper for 12 weeks led to significant improvements in symptoms of UI, and 
these symptoms did not recur immediately even when the participants stopped wearing the 
shaper for one week. The effect was found to be valid not only in women with SUI but also 
in those with MUI. Wearing the shaper was also found to be effective even against severe 
UI, and 85.4% of the participants showed an improvement in the symptoms. The strengths 
of this study include the low dropout rate, high adherence rate, and the fact that the 
assessment of the bladder neck position was conducted using MRI in a sitting posture, 
which was close to the posture subject to vertical gravity in which urinary leakage was 
likely to occur. 
By wearing the shaper, since all participants accepted elevation of the bladder neck, the 
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shaper could potentially have an effect of reducing the symptoms of SUI in all participants. 
The participants included in this study showed a large range of age, and time since last 
delivery. However, since the effect of wearing the shaper to elevate the bladder neck was 
large, it is thought that these two variables did not affect the outcome. 
In a previous study, Fielding and his group
13
 reported that the bladder neck position of 
eight women with SUI (years of age; 45–69) was an average of 22 mm below the PC line in 
sitting posture. The discrepancy in this and our study may be attributed to the differences in 
sample size and characteristics of the study population. Although the normal position of the 
bladder neck was not well-defined for the participants in this study, urinary leakage did not 
occur "at rest", but occurred "at pelvic strain" in women with SUI, therefore it was based 
on position "at rest". When wearing the shaper, the bladder neck position "at pelvic strain" 
was maintained at the same position as "at rest" without the shaper, thus it could have 
prevented the urinary leakage. In addition, the bladder neck was open "at pelvic strain" 
without wearing the shaper, but it was flat "at pelvic strain" with wearing the shaper. Miller 
and his group
14
 reported that no urinary leakage occurs when a contraction of the PFM is 
performed at the moment of a sneezing or a cough (the Knack maneuver). In this study, 
simply wearing the shaper allowed the bladder neck to reach an elevation higher than that 
"at PFM contraction" without wearing the shaper. 
The reasons why the shaper could have led to the elevation of the bladder neck could be 
as follows: it did not have strong support power for the abdomen, and it led to the elevation 
of not only the bladder neck but also the fundus of the bladder, suggesting that it was 
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effective to lift the gluteal region from behind. According to the integral theory of female 
UI
15
,
 
the normal pelvic floor function is considered analogous to a suspension bridge, and 
structure and function of pelvic floor are related mutually. The supportive power of 
underwear is believed to complement the strength of internal muscles, fascia and ligaments, 
and keep the structure of the pelvic floor in a balanced state. We estimate that this balanced 
state will be a mechanism effective in improving UI by the shaper. 
After wearing the shaper for 12 weeks, the bladder neck position was found to be 
elevated even without wearing the shaper, and the symptoms of UI did not immediately 
recur after the use of the shaper was discontinued. Braekken and his group
16
 previously 
reported having achieved a 4.3 mm (95% CI, 2.1–6.5) elevation of the position of the 
bladder through 6 months of PFM training. The shaper used in this study is designed to 
strengthen the muscles of buttocks. Possibly, wearing the shaper for 12 weeks might have 
influenced not only these muscles, but also the muscles of PFM. This might be associated 
with the fact that the shape of the bladder "at rest" while wearing the shaper resembled that 
"at PFM contraction" without the shaper, and also with the fact that merely by wearing the 
shaper, the bladder neck position can be elevated higher than "at PFM contraction" without 
the shaper. However, although the patent of buttocks muscles strengthening by wearing the 
shaper and walking was acquired, there is no report that shows the scientific evidence of i t. 
In addition, the number of steps did not correlate with the reduction of UI and elevation of 
the bladder neck position after 12 weeks. 
In this study, we were not able to show clearly why wearing the shaper could have led to 
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the elevation of the bladder neck, and which parts of the support power of the shaper led to 
the elevation of the bladder neck, which was more effective in reducing the symptoms of 
UI between the elevation of the bladder neck or the PFM strengthening. It is important to 
elucidate these mechanisms in the future. 
The limitations of this study were that it was the first trial, and it was not a randomized 
controlled trial but a before-after design without any control groups. Therefore, the result 
of this study cannot deny the placebo effect. Moreover, MRIs were analyzed by one 
researcher who was not blinded. In addition, the changes in the strength of PFM were not 
directly evaluated. However, the effect of elevating the bladder neck and in reducing 
symptoms of UI was enough to cover these imperfections. 
In the participants of this study, although urination was stopped for an hour before MRI, 
bladder volume was not fixed. However, since there was no clear difference in the bladder 
volume of the same participant, probably, it has very little influence on the result. 
The treatment of SUI often imposes a number of burdens on women. Although PFM 
training can achieve a 35–80% improvement rate17, adherence decreases in the long-term18. 
In addition, since 30% of women cannot contract their PFM correctly, PFM training is 
ineffective in such women
19
. For biofeedback and functional electrical stimulation, regular 
hospital visits are necessary. In contrast, wearing the shaper is easy, and does not interfere 
with daily life. The improvement rate of the symptoms of UI by wearing the shaper was 
85.4%, and it was effective not only in mild SUI, but also in MUI and severe UI. Wearing 
the shaper may expand the possibility of the treatment of UI. 
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In conclusion, wearing the shaper elevated the bladder neck in all participants, and use of 
the shaper for 12 weeks led to significant improvements in symptoms of UI. In addition, 
symptoms of UI did not recur immediately even when the participants stopped wearing the 
shaper. Although a randomized controlled trial, short or long-term evaluation, and the 
elucidation of mechanism to elevate the bladder neck and to reduce the symptoms of UI 
will be required, this pilot study has demonstrated that the use of underwear might be a 
promising treatment option for management of UI symptoms. 
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Figure 1. Flow diagram of the study. 
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Figure 2. Sagittal T1-weighted pelvic magnetic resonance images of a 34-year-old 
woman.  
A, B, C (top panel) show the images without the shaper, and D, E, F (bottom panel) show 
the images with the shaper. Arrows point to the bladder neck positions; white line indicates 
the pubococcygeal line. “At rest,” the bladder neck was clearly higher with  than without 
the shaper (A vs. D, 14.2 mm). “At pelvic floor muscle (PFM) contraction” without the 
shaper, the position and shape of the bladder were similar to “at rest” with the shaper (B vs. 
D). “At pelvic strain” with the shaper, the bladder neck was flat (C vs. F), and the position 
was similar to “at rest” without shaper (A vs. F). 
 
A; Without shaper
   “At rest”
B; Without shaper
    “At PFM contraction”
C; Without shaper
    “At pelvic stain”
D; With shaper
   “At rest”
E; With shaper
    “At PFM contraction”
F; With shaper
    “At pelvic stain”
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Table 1. Baseline characteristics of participants (n = 45) 
 
 Median [25th–75th percentile] 
Age (years)  43.0 [35.5, 51.5] 
Body mass index (kg/m
2
)  21.4 [19.8, 22.9] 
Parity (no. of childbirths) 2.0 [2.0, 2.0] 
Time since last delivery (years) 8.0 [2.0, 22.5] 
Type of urinary incontinence (UI), n (%)  
Stress urinary incontinence (SUI) 29 (64.4%) 
Mixed urinary incontinence (MUI) 16 (35.6%) 
Severity of UI (based on the 1-hour pad test), n (%)  
Slight, < 2 g 26 (57.8%) 
Mild, ≥ 2–5 g 11 (24.4%) 
Moderate, ≥ 5–10 g 5 (11.1%) 
Severe, ≥ 10 g 3 (6.7%) 
The experience of pelvic floor muscle training, n (%) 16 (35.6%) 
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Table 2. Effect of wearing the shaper on the bladder neck position from pubococygeal line in women at baseline (n = 45) 
 
  
I: Without the shaper (mm) II: With the shaper  Difference between I and II
†
 P-value
‡ 
Median [25th–75th percentile] Median [25th–75th percentile] Median (95% CI)                            
At rest  A: 0.0 [-5.0, 7.1] D: 11.7 [6.3, 17.8] 11.5 (10.0, 12.9) < 0.001* 
At PFM contraction B: 6.9 [2.3, 14.0] E: 14.2 [10.4, 21.8] 7.3 (6.0, 8.8) < 0.001* 
At pelvic strain C: -10.9 [-18.0, -2.2] F: 0.9 [-9.9, 8.9] 8.7 (6.6, 10.7) < 0.001* 
A vs. F   0.5 (-2.1, 3.3) 0.710 
B vs. D   4.4 (1.8, 6.6)  0.002* 
†
 Hodges-Lehmann estimator.  
‡ 
Wilcoxon signed-ranks test and Bonferroni correction: *P < 0.008 (= 0.05/6). 
PFM, Pelvic Floor Muscle. 
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Table 3. Effects of wearing the shaper on symptoms of urinary incontinence and the bladder neck position (n = 41) 
 
 A: baseline B: 6 week C: 12 week D: follow-up 
Difference
†
 
between A and C 
A Vs. B. A Vs. C B Vs. C 
Difference
†
 
between C and D 
C Vs. D  
Outcome measure Median [25th–75th percentile] Median (95% CI)  P-value‡  Median (95% CI) P-value§ 
The symptoms of UI 
1-hour pad test (g) 
 
1.0 [0.0, 3.0] 
 
0.0 [0.0, 1.5]  
 
0.0 [0.0, 0.0] 
 
0.0 [0.0, 0.0] 
  
0.002** 
 
<0.001** 
 
0.007* 
  
0.589 
ICIQ-SF 7.0 [5.0, 11.0] 5.0 [3.5, 7.0]  4.0 [0.0, 6.0] 4.0 [0.0, 5.0]  <0.001** <0.001** <0.001**  0.928 
Incontinence episodes/week 4.0 [1.5, 7.0] 0.0 [0.0, 1.0]  0.0 [0.0, 1.0] 0.0 [0.0, 1.0]  <0.001** <0.001** 0.018  0.103 
Frequency of voiding/day 7.7 [ 6.7, 9.0] 7.4 [6.3, 8.5] 7.0 [6.2, 8.0] 7.0 [6.1, 8.4]  0.204 0.003* 0.044  0.512 
Bladder neck position (mm) 0.0 [-5.0, 7.8] NA 4.7[-2.8,11.1] 7.6 [1.8, 13.2] 4.7 (2.8, 6.6) NA <0.001** NA 1.7 (-0.5, 4.3) 0.141 
†
Hodges-Lehmann estimator.  
‡
Wilcoxon signed-rank test and Bonferroni correction: *P < 0.016 (= 0.05/3), **P < 0.003 (= 0.01/3). 
§
Wilcoxon signed-ranks test. 
UI, urinary incontinence, ICIQ-SF, International Consultation Incontinence Questionnaire Short Form 
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Table 4. The decrease in the rate of symptoms of UI after 12 weeks 
 
Decrease of symptoms Overall (n = 41) SUI (n = 25) MUI (n = 16) 
Disappearance
† 
 27 (65.9%) 16 (64.0%) 11 (68.8%) 
Reduction 
‡ 
 8 (19.5%) 6 (24.0%) 2 (12.5%) 
No change  6 (14.6%) 3 (12.0%) 3 (18.8%) 
Aggravation  0 (0.0%) 0 (0.0%) 0 (0.0%) 
†Disappearance; both 1-hour pad test and incontinence episodes/week showed 0. 
‡Reduction; both 1-hour pad test and incontinence episodes/week showed less than 50% decreases from 
baseline. 
MUI, Mixed Urinary Incontinence. SUI, Stress Urinary Incontinence.  
 
 
 
 
